Clinical Trials Browser

OTHER × Oligodendroglioma × Tretinoin × Clear all

NCT05345002 2026-02-20

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Phase 2 Recruiting

Astrocytoma, Glioma, Oligodendroglioma